3Bos JD. Psoriasis,innate immunity, and gene pools. J Am Acad Dermatol,2007,56(3) :468 -471.
4Fearon DT,Locksley RM. The instructive role of innate immunity in the acquired immune response[ J ]. Science, 1996,272 (5258) :50 - 53.
5Birch KE, Vukmanovic-Stejic M, Reed JR, et al. The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin [ J ]. Br J Dermatol, 2005,152 ( 3 ) :409 - 417.
6Beissert S,Schwarz A,Schwarz T. Regulatory T cells[ J ]. J Invest Dermatol,2006,126 ( 1 ) : 15 - 24.
7Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3 [ J ]. Science ,2003,299 (5609) : 1057 - 1061.
8Wan YY, Flavell RA. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression [ J ]. Nature, 2007,445 (7129) :766 -770.
9Selvaraj RK, Geiger TL. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta[ J ]. J Immunol,2007,178 ( 12 ) :7667 - 7677.
10Miyara M, Sakaguehi S. Natural regulatory T cells:mechanisms of suppression [ J ]. Trends Mol Med,2007,13 (3) : 108 - 116.
3Friedrich M,Krammig S,Henze M,ct al.Flow cytometric characterization of lesional T cells in psoriasis:intracellular cytokine and surface antigen expression indicates an activated,memory/effector type 1 immunophenotype.Arch Dermatol Res,2000,292:519-521.
4Ovigne JM,Baker BS,Brown DW,et al.Epidermal CD8+ T cells in chronic plaque psoriasis are Tcl cells producing heterogeneous levels of interferon-gamma.Exp Dermatol,2001,10:168-174.
5Szegedi A,Aleksza M,Gonda A,et al.Elevated rate of Thelperl (T(H) 1) lymphocytes and serum IFN-gamma levels in psoriatic patients.Immunol Lett,2003,86:277-280.
6Ghoreschi K,Rocken M.Immune deviation strategies in the therapy of psoriasis.Curr Drug Targets Inflamm Allergy,2004,3:193-198.
7Ghoreschi K,Thomas P,Breit S,et al.Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease.Nat Med,2003,9:40-46.
8Kawamura A,Adachi K,Ishihara S,et al.Correlation between microsatellite instability and metachronous disease recurrence after endoscopic mucosal resection in patients with early stage gastric carcinoma.Cancer,2001,91:339-345.
9Wittmann M,Purwar R,Hartmann C,et al.Human keratinocytes respond to interleukin-18:implication for the course of chronic inflammatory skin diseases.J Invest Dermatol,2005,124:1225-1233.
10Bozza M,Bliss JL,Dorner AJ,et al.Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells.J Interferon Cytokine Res,2001,21:21-30.
3Sugiyama H,Gyulai R,Toichi E et al. Dysfunctional blood and target tissue CD4^+ CD25^+ high regulatory T cell in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation[ J]. J Immunol,2005,174( 1 ) : 164.
4Beissert S, Schwarz A, Schwarz T. Regulatory T cells [ J ]. J Invest Dermatol,2006,126 ( 1 ) : 15.
5Shen Z,Chen L,Wang Get al. Reply: Keratin 17/interferon-gamma autoimmune loop as a vicious circle driving psoriasis pathogenesis [ J ]. J Am Acad Dermatol, 2007, 56(1) : 162.
6Meyer-Hoffert U, Wingertszahn J, Wiedow O. Human leukocyte elastase induces keratinoeyte proliferation by epidermal growth factor receptor activation[J]. J Invest Dermatol, 2004, 123 ( 2 ) : 338-345.
7MacDonald N, Cumberhatch M, Singh M, et al. Proteomic analysis of suction blister fluid isolated from human skin[J]. Clin Exp Dermatol, 2006, 31 (3) : 445-448.
8Horwitz M, Duan Z, Korkmaz B, et al.Neutrophil elastase in cyclic and severe congenital neutropenia[J].Blood, 2007, 109 ( 8 ) : 1817-1824.
